nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—lung cancer—melanoma	0.769	1	CtDrD
Pemetrexed—ATIC—pes—melanoma	0.0135	0.214	CbGeAlD
Pemetrexed—ATIC—leg—melanoma	0.0069	0.109	CbGeAlD
Pemetrexed—ATIC—hindlimb—melanoma	0.00616	0.0975	CbGeAlD
Pemetrexed—ATIC—appendage—melanoma	0.00529	0.0836	CbGeAlD
Pemetrexed—ATIC—skin epidermis—melanoma	0.0044	0.0696	CbGeAlD
Pemetrexed—GART—eye—melanoma	0.00231	0.0365	CbGeAlD
Pemetrexed—SLC46A1—eye—melanoma	0.00187	0.0296	CbGeAlD
Pemetrexed—TYMS—Paclitaxel—Docetaxel—melanoma	0.00186	1	CbGdCrCtD
Pemetrexed—GART—mammalian vulva—melanoma	0.00183	0.0289	CbGeAlD
Pemetrexed—ATIC—eye—melanoma	0.00157	0.0248	CbGeAlD
Pemetrexed—ATIC—retina—melanoma	0.00155	0.0245	CbGeAlD
Pemetrexed—ATIC—skin of body—melanoma	0.00136	0.0215	CbGeAlD
Pemetrexed—GART—head—melanoma	0.00131	0.0207	CbGeAlD
Pemetrexed—SLC46A1—head—melanoma	0.00106	0.0168	CbGeAlD
Pemetrexed—DHFR—eye—melanoma	0.00105	0.0166	CbGeAlD
Pemetrexed—DHFR—retina—melanoma	0.00104	0.0165	CbGeAlD
Pemetrexed—TYMS—skin of body—melanoma	0.000924	0.0146	CbGeAlD
Pemetrexed—GART—lymph node—melanoma	0.000916	0.0145	CbGeAlD
Pemetrexed—DCK—retina—melanoma	0.000901	0.0143	CbGeAlD
Pemetrexed—ATIC—head—melanoma	0.000889	0.0141	CbGeAlD
Pemetrexed—TYMS—mammalian vulva—melanoma	0.000843	0.0133	CbGeAlD
Pemetrexed—DHFR—mammalian vulva—melanoma	0.000834	0.0132	CbGeAlD
Pemetrexed—SLC29A1—mammalian vulva—melanoma	0.000756	0.012	CbGeAlD
Pemetrexed—SLC46A1—lymph node—melanoma	0.000744	0.0118	CbGeAlD
Pemetrexed—DCK—mammalian vulva—melanoma	0.000722	0.0114	CbGeAlD
Pemetrexed—ATIC—lymph node—melanoma	0.000622	0.00984	CbGeAlD
Pemetrexed—TYMS—head—melanoma	0.000603	0.00954	CbGeAlD
Pemetrexed—DHFR—head—melanoma	0.000597	0.00944	CbGeAlD
Pemetrexed—SLC29A1—head—melanoma	0.000541	0.00855	CbGeAlD
Pemetrexed—DCK—head—melanoma	0.000516	0.00817	CbGeAlD
Pemetrexed—TYMS—lymph node—melanoma	0.000422	0.00668	CbGeAlD
Pemetrexed—DHFR—lymph node—melanoma	0.000418	0.00661	CbGeAlD
Pemetrexed—SLC29A1—lymph node—melanoma	0.000378	0.00599	CbGeAlD
Pemetrexed—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000378	0.00373	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000378	0.00373	CcSEcCtD
Pemetrexed—Lacrimation increased—Docetaxel—melanoma	0.000378	0.00372	CcSEcCtD
Pemetrexed—Pancytopenia—Bleomycin—melanoma	0.00037	0.00364	CcSEcCtD
Pemetrexed—Anaphylactic shock—Vemurafenib—melanoma	0.000366	0.0036	CcSEcCtD
Pemetrexed—Dysphagia—Dactinomycin—melanoma	0.000363	0.00358	CcSEcCtD
Pemetrexed—Infection—Vemurafenib—melanoma	0.000363	0.00358	CcSEcCtD
Pemetrexed—DCK—lymph node—melanoma	0.000362	0.00572	CbGeAlD
Pemetrexed—Mood swings—Temozolomide—melanoma	0.00036	0.00355	CcSEcCtD
Pemetrexed—Nervous system disorder—Vemurafenib—melanoma	0.000359	0.00353	CcSEcCtD
Pemetrexed—Skin disorder—Vemurafenib—melanoma	0.000355	0.0035	CcSEcCtD
Pemetrexed—Respiratory failure—Docetaxel—melanoma	0.000355	0.00349	CcSEcCtD
Pemetrexed—Dehydration—Temozolomide—melanoma	0.000354	0.00348	CcSEcCtD
Pemetrexed—Pulmonary embolism—Docetaxel—melanoma	0.000348	0.00343	CcSEcCtD
Pemetrexed—Pancytopenia—Dactinomycin—melanoma	0.000345	0.0034	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Bleomycin—melanoma	0.000342	0.00337	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000342	0.00337	CcSEcCtD
Pemetrexed—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000342	0.00337	CcSEcCtD
Pemetrexed—Myocardial infarction—Bleomycin—melanoma	0.00034	0.00335	CcSEcCtD
Pemetrexed—Dysphagia—Carmustine—melanoma	0.00034	0.00335	CcSEcCtD
Pemetrexed—Neutropenia—Dactinomycin—melanoma	0.00034	0.00334	CcSEcCtD
Pemetrexed—Stomatitis—Bleomycin—melanoma	0.000339	0.00333	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Temozolomide—melanoma	0.000335	0.0033	CcSEcCtD
Pemetrexed—Colitis—Docetaxel—melanoma	0.000334	0.00329	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000333	0.00328	CcSEcCtD
Pemetrexed—Skin exfoliation—Docetaxel—melanoma	0.000333	0.00327	CcSEcCtD
Pemetrexed—Dysphagia—Temozolomide—melanoma	0.000329	0.00323	CcSEcCtD
Pemetrexed—Neuropathy—Docetaxel—melanoma	0.000327	0.00322	CcSEcCtD
Pemetrexed—Pancytopenia—Carmustine—melanoma	0.000323	0.00318	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000321	0.00316	CcSEcCtD
Pemetrexed—Oesophagitis—Docetaxel—melanoma	0.000318	0.00313	CcSEcCtD
Pemetrexed—Neutropenia—Carmustine—melanoma	0.000318	0.00313	CcSEcCtD
Pemetrexed—Decreased appetite—Vemurafenib—melanoma	0.000318	0.00313	CcSEcCtD
Pemetrexed—Stomatitis—Dactinomycin—melanoma	0.000316	0.00311	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Vemurafenib—melanoma	0.000316	0.00311	CcSEcCtD
Pemetrexed—Fatigue—Vemurafenib—melanoma	0.000315	0.0031	CcSEcCtD
Pemetrexed—Constipation—Vemurafenib—melanoma	0.000313	0.00308	CcSEcCtD
Pemetrexed—Pancytopenia—Temozolomide—melanoma	0.000312	0.00307	CcSEcCtD
Pemetrexed—Neutropenia—Temozolomide—melanoma	0.000307	0.00302	CcSEcCtD
Pemetrexed—Agranulocytosis—Dactinomycin—melanoma	0.000302	0.00298	CcSEcCtD
Pemetrexed—Sepsis—Docetaxel—melanoma	0.000302	0.00298	CcSEcCtD
Pemetrexed—Renal failure—Carmustine—melanoma	0.000298	0.00293	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Carmustine—melanoma	0.000297	0.00293	CcSEcCtD
Pemetrexed—Stomatitis—Carmustine—melanoma	0.000295	0.00291	CcSEcCtD
Pemetrexed—Infestation NOS—Temozolomide—melanoma	0.000293	0.00288	CcSEcCtD
Pemetrexed—Infestation—Temozolomide—melanoma	0.000293	0.00288	CcSEcCtD
Pemetrexed—Hepatitis—Dactinomycin—melanoma	0.000291	0.00286	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00029	0.00286	CcSEcCtD
Pemetrexed—Body temperature increased—Vemurafenib—melanoma	0.000289	0.00285	CcSEcCtD
Pemetrexed—Pharyngitis—Dactinomycin—melanoma	0.000289	0.00284	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Temozolomide—melanoma	0.000287	0.00283	CcSEcCtD
Pemetrexed—Stomatitis—Temozolomide—melanoma	0.000286	0.00281	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Temozolomide—melanoma	0.000277	0.00273	CcSEcCtD
Pemetrexed—Alopecia—Bleomycin—melanoma	0.000276	0.00271	CcSEcCtD
Pemetrexed—Erythema multiforme—Dactinomycin—melanoma	0.000275	0.00271	CcSEcCtD
Pemetrexed—Erythema—Bleomycin—melanoma	0.000271	0.00267	CcSEcCtD
Pemetrexed—Hypersensitivity—Vemurafenib—melanoma	0.000269	0.00265	CcSEcCtD
Pemetrexed—Hepatitis—Temozolomide—melanoma	0.000263	0.00259	CcSEcCtD
Pemetrexed—Asthenia—Vemurafenib—melanoma	0.000262	0.00258	CcSEcCtD
Pemetrexed—Pharyngitis—Temozolomide—melanoma	0.000261	0.00257	CcSEcCtD
Pemetrexed—Urinary tract disorder—Temozolomide—melanoma	0.00026	0.00256	CcSEcCtD
Pemetrexed—Pruritus—Vemurafenib—melanoma	0.000259	0.00255	CcSEcCtD
Pemetrexed—Urethral disorder—Temozolomide—melanoma	0.000258	0.00254	CcSEcCtD
Pemetrexed—Alopecia—Dactinomycin—melanoma	0.000257	0.00253	CcSEcCtD
Pemetrexed—Eye disorder—Carmustine—melanoma	0.000254	0.0025	CcSEcCtD
Pemetrexed—Erythema—Dactinomycin—melanoma	0.000253	0.00249	CcSEcCtD
Pemetrexed—Anaemia—Bleomycin—melanoma	0.000251	0.00247	CcSEcCtD
Pemetrexed—Diarrhoea—Vemurafenib—melanoma	0.00025	0.00246	CcSEcCtD
Pemetrexed—Erythema multiforme—Temozolomide—melanoma	0.000249	0.00245	CcSEcCtD
Pemetrexed—Eye disorder—Temozolomide—melanoma	0.000246	0.00242	CcSEcCtD
Pemetrexed—Arrhythmia—Carmustine—melanoma	0.000243	0.00239	CcSEcCtD
Pemetrexed—Leukopenia—Bleomycin—melanoma	0.000243	0.00239	CcSEcCtD
Pemetrexed—Dizziness—Vemurafenib—melanoma	0.000242	0.00238	CcSEcCtD
Pemetrexed—Alopecia—Carmustine—melanoma	0.00024	0.00237	CcSEcCtD
Pemetrexed—Malnutrition—Carmustine—melanoma	0.000237	0.00233	CcSEcCtD
Pemetrexed—Erythema—Carmustine—melanoma	0.000237	0.00233	CcSEcCtD
Pemetrexed—Dehydration—Docetaxel—melanoma	0.000235	0.00231	CcSEcCtD
Pemetrexed—Anaemia—Dactinomycin—melanoma	0.000234	0.0023	CcSEcCtD
Pemetrexed—Vomiting—Vemurafenib—melanoma	0.000232	0.00229	CcSEcCtD
Pemetrexed—Alopecia—Temozolomide—melanoma	0.000232	0.00229	CcSEcCtD
Pemetrexed—Myalgia—Bleomycin—melanoma	0.000231	0.00227	CcSEcCtD
Pemetrexed—Chest pain—Bleomycin—melanoma	0.000231	0.00227	CcSEcCtD
Pemetrexed—Rash—Vemurafenib—melanoma	0.000231	0.00227	CcSEcCtD
Pemetrexed—Dermatitis—Vemurafenib—melanoma	0.00023	0.00227	CcSEcCtD
Pemetrexed—Erythema—Temozolomide—melanoma	0.000229	0.00225	CcSEcCtD
Pemetrexed—Malnutrition—Temozolomide—melanoma	0.000229	0.00225	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000228	0.00224	CcSEcCtD
Pemetrexed—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000228	0.00224	CcSEcCtD
Pemetrexed—Leukopenia—Dactinomycin—melanoma	0.000227	0.00223	CcSEcCtD
Pemetrexed—Dysgeusia—Temozolomide—melanoma	0.000224	0.00221	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Docetaxel—melanoma	0.000223	0.0022	CcSEcCtD
Pemetrexed—Oedema—Bleomycin—melanoma	0.000222	0.00218	CcSEcCtD
Pemetrexed—Anaphylactic shock—Bleomycin—melanoma	0.000222	0.00218	CcSEcCtD
Pemetrexed—Infection—Bleomycin—melanoma	0.00022	0.00217	CcSEcCtD
Pemetrexed—Anaemia—Carmustine—melanoma	0.000219	0.00216	CcSEcCtD
Pemetrexed—Dysphagia—Docetaxel—melanoma	0.000219	0.00215	CcSEcCtD
Pemetrexed—Nausea—Vemurafenib—melanoma	0.000217	0.00214	CcSEcCtD
Pemetrexed—Thrombocytopenia—Bleomycin—melanoma	0.000217	0.00214	CcSEcCtD
Pemetrexed—Myalgia—Dactinomycin—melanoma	0.000215	0.00212	CcSEcCtD
Pemetrexed—Angina pectoris—Docetaxel—melanoma	0.000213	0.0021	CcSEcCtD
Pemetrexed—Leukopenia—Carmustine—melanoma	0.000212	0.00209	CcSEcCtD
Pemetrexed—Anaemia—Temozolomide—melanoma	0.000212	0.00208	CcSEcCtD
Pemetrexed—Anorexia—Bleomycin—melanoma	0.000211	0.00208	CcSEcCtD
Pemetrexed—Pancytopenia—Docetaxel—melanoma	0.000208	0.00204	CcSEcCtD
Pemetrexed—Oedema—Dactinomycin—melanoma	0.000207	0.00203	CcSEcCtD
Pemetrexed—Infection—Dactinomycin—melanoma	0.000205	0.00202	CcSEcCtD
Pemetrexed—Leukopenia—Temozolomide—melanoma	0.000205	0.00202	CcSEcCtD
Pemetrexed—Hypertension—Carmustine—melanoma	0.000205	0.00201	CcSEcCtD
Pemetrexed—Neutropenia—Docetaxel—melanoma	0.000204	0.00201	CcSEcCtD
Pemetrexed—Thrombocytopenia—Dactinomycin—melanoma	0.000202	0.00199	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Bleomycin—melanoma	0.000202	0.00199	CcSEcCtD
Pemetrexed—Myalgia—Carmustine—melanoma	0.000202	0.00199	CcSEcCtD
Pemetrexed—Chest pain—Carmustine—melanoma	0.000202	0.00199	CcSEcCtD
Pemetrexed—Hypertension—Temozolomide—melanoma	0.000198	0.00195	CcSEcCtD
Pemetrexed—Dyspnoea—Bleomycin—melanoma	0.000197	0.00194	CcSEcCtD
Pemetrexed—Anorexia—Dactinomycin—melanoma	0.000197	0.00194	CcSEcCtD
Pemetrexed—Arthralgia—Temozolomide—melanoma	0.000195	0.00192	CcSEcCtD
Pemetrexed—Myalgia—Temozolomide—melanoma	0.000195	0.00192	CcSEcCtD
Pemetrexed—Infestation—Docetaxel—melanoma	0.000195	0.00192	CcSEcCtD
Pemetrexed—Infestation NOS—Docetaxel—melanoma	0.000195	0.00192	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000194	0.00191	CcSEcCtD
Pemetrexed—Oedema—Carmustine—melanoma	0.000193	0.0019	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000193	0.0019	CcSEcCtD
Pemetrexed—Decreased appetite—Bleomycin—melanoma	0.000193	0.0019	CcSEcCtD
Pemetrexed—Infection—Carmustine—melanoma	0.000192	0.00189	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Docetaxel—melanoma	0.000192	0.00189	CcSEcCtD
Pemetrexed—Renal failure—Docetaxel—melanoma	0.000192	0.00189	CcSEcCtD
Pemetrexed—Myocardial infarction—Docetaxel—melanoma	0.000191	0.00188	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Docetaxel—melanoma	0.000191	0.00188	CcSEcCtD
Pemetrexed—Stomatitis—Docetaxel—melanoma	0.00019	0.00187	CcSEcCtD
Pemetrexed—Pain—Bleomycin—melanoma	0.000189	0.00186	CcSEcCtD
Pemetrexed—Conjunctivitis—Docetaxel—melanoma	0.000189	0.00186	CcSEcCtD
Pemetrexed—Thrombocytopenia—Carmustine—melanoma	0.000189	0.00186	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000188	0.00185	CcSEcCtD
Pemetrexed—Oedema—Temozolomide—melanoma	0.000187	0.00184	CcSEcCtD
Pemetrexed—Anaphylactic shock—Temozolomide—melanoma	0.000187	0.00184	CcSEcCtD
Pemetrexed—Infection—Temozolomide—melanoma	0.000186	0.00183	CcSEcCtD
Pemetrexed—Anorexia—Carmustine—melanoma	0.000184	0.00181	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Docetaxel—melanoma	0.000184	0.00181	CcSEcCtD
Pemetrexed—Nervous system disorder—Temozolomide—melanoma	0.000183	0.0018	CcSEcCtD
Pemetrexed—Thrombocytopenia—Temozolomide—melanoma	0.000183	0.0018	CcSEcCtD
Pemetrexed—Agranulocytosis—Docetaxel—melanoma	0.000182	0.00179	CcSEcCtD
Pemetrexed—Skin disorder—Temozolomide—melanoma	0.000181	0.00179	CcSEcCtD
Pemetrexed—Decreased appetite—Dactinomycin—melanoma	0.00018	0.00177	CcSEcCtD
Pemetrexed—Fatigue—Dactinomycin—melanoma	0.000178	0.00175	CcSEcCtD
Pemetrexed—Anorexia—Temozolomide—melanoma	0.000178	0.00175	CcSEcCtD
Pemetrexed—Pain—Dactinomycin—melanoma	0.000177	0.00174	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Carmustine—melanoma	0.000176	0.00173	CcSEcCtD
Pemetrexed—Urticaria—Bleomycin—melanoma	0.000176	0.00173	CcSEcCtD
Pemetrexed—Body temperature increased—Bleomycin—melanoma	0.000175	0.00172	CcSEcCtD
Pemetrexed—Hepatitis—Docetaxel—melanoma	0.000175	0.00172	CcSEcCtD
Pemetrexed—Pharyngitis—Docetaxel—melanoma	0.000174	0.00171	CcSEcCtD
Pemetrexed—Urinary tract disorder—Docetaxel—melanoma	0.000173	0.0017	CcSEcCtD
Pemetrexed—Dyspnoea—Carmustine—melanoma	0.000172	0.0017	CcSEcCtD
Pemetrexed—Urethral disorder—Docetaxel—melanoma	0.000171	0.00169	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Temozolomide—melanoma	0.00017	0.00168	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Dactinomycin—melanoma	0.000169	0.00166	CcSEcCtD
Pemetrexed—Decreased appetite—Carmustine—melanoma	0.000168	0.00165	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Carmustine—melanoma	0.000167	0.00164	CcSEcCtD
Pemetrexed—Dyspnoea—Temozolomide—melanoma	0.000167	0.00164	CcSEcCtD
Pemetrexed—Erythema multiforme—Docetaxel—melanoma	0.000165	0.00163	CcSEcCtD
Pemetrexed—Pain—Carmustine—melanoma	0.000165	0.00163	CcSEcCtD
Pemetrexed—Constipation—Carmustine—melanoma	0.000165	0.00163	CcSEcCtD
Pemetrexed—Dyspepsia—Temozolomide—melanoma	0.000164	0.00162	CcSEcCtD
Pemetrexed—Eye disorder—Docetaxel—melanoma	0.000163	0.00161	CcSEcCtD
Pemetrexed—Abdominal pain—Dactinomycin—melanoma	0.000163	0.00161	CcSEcCtD
Pemetrexed—Body temperature increased—Dactinomycin—melanoma	0.000163	0.00161	CcSEcCtD
Pemetrexed—Hypersensitivity—Bleomycin—melanoma	0.000163	0.00161	CcSEcCtD
Pemetrexed—Decreased appetite—Temozolomide—melanoma	0.000162	0.0016	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Temozolomide—melanoma	0.000161	0.00159	CcSEcCtD
Pemetrexed—Fatigue—Temozolomide—melanoma	0.000161	0.00159	CcSEcCtD
Pemetrexed—Constipation—Temozolomide—melanoma	0.00016	0.00157	CcSEcCtD
Pemetrexed—Pain—Temozolomide—melanoma	0.00016	0.00157	CcSEcCtD
Pemetrexed—Asthenia—Bleomycin—melanoma	0.000159	0.00156	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Carmustine—melanoma	0.000158	0.00156	CcSEcCtD
Pemetrexed—Pruritus—Bleomycin—melanoma	0.000157	0.00154	CcSEcCtD
Pemetrexed—Arrhythmia—Docetaxel—melanoma	0.000156	0.00154	CcSEcCtD
Pemetrexed—Alopecia—Docetaxel—melanoma	0.000155	0.00152	CcSEcCtD
Pemetrexed—Body temperature increased—Carmustine—melanoma	0.000153	0.0015	CcSEcCtD
Pemetrexed—Abdominal pain—Carmustine—melanoma	0.000153	0.0015	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Temozolomide—melanoma	0.000153	0.0015	CcSEcCtD
Pemetrexed—Malnutrition—Docetaxel—melanoma	0.000152	0.0015	CcSEcCtD
Pemetrexed—Erythema—Docetaxel—melanoma	0.000152	0.0015	CcSEcCtD
Pemetrexed—Hypersensitivity—Dactinomycin—melanoma	0.000152	0.0015	CcSEcCtD
Pemetrexed—Dysgeusia—Docetaxel—melanoma	0.000149	0.00147	CcSEcCtD
Pemetrexed—Urticaria—Temozolomide—melanoma	0.000148	0.00146	CcSEcCtD
Pemetrexed—Asthenia—Dactinomycin—melanoma	0.000148	0.00146	CcSEcCtD
Pemetrexed—Abdominal pain—Temozolomide—melanoma	0.000148	0.00145	CcSEcCtD
Pemetrexed—Body temperature increased—Temozolomide—melanoma	0.000148	0.00145	CcSEcCtD
Pemetrexed—Hypersensitivity—Carmustine—melanoma	0.000142	0.0014	CcSEcCtD
Pemetrexed—Diarrhoea—Dactinomycin—melanoma	0.000141	0.00139	CcSEcCtD
Pemetrexed—Vomiting—Bleomycin—melanoma	0.000141	0.00139	CcSEcCtD
Pemetrexed—Anaemia—Docetaxel—melanoma	0.000141	0.00139	CcSEcCtD
Pemetrexed—Rash—Bleomycin—melanoma	0.00014	0.00137	CcSEcCtD
Pemetrexed—Dermatitis—Bleomycin—melanoma	0.00014	0.00137	CcSEcCtD
Pemetrexed—Asthenia—Carmustine—melanoma	0.000139	0.00137	CcSEcCtD
Pemetrexed—Hypersensitivity—Temozolomide—melanoma	0.000138	0.00136	CcSEcCtD
Pemetrexed—Syncope—Docetaxel—melanoma	0.000137	0.00134	CcSEcCtD
Pemetrexed—Leukopenia—Docetaxel—melanoma	0.000136	0.00134	CcSEcCtD
Pemetrexed—Asthenia—Temozolomide—melanoma	0.000134	0.00132	CcSEcCtD
Pemetrexed—Loss of consciousness—Docetaxel—melanoma	0.000134	0.00132	CcSEcCtD
Pemetrexed—Diarrhoea—Carmustine—melanoma	0.000132	0.0013	CcSEcCtD
Pemetrexed—Pruritus—Temozolomide—melanoma	0.000132	0.0013	CcSEcCtD
Pemetrexed—Nausea—Bleomycin—melanoma	0.000132	0.0013	CcSEcCtD
Pemetrexed—Hypertension—Docetaxel—melanoma	0.000131	0.00129	CcSEcCtD
Pemetrexed—Vomiting—Dactinomycin—melanoma	0.000131	0.00129	CcSEcCtD
Pemetrexed—Rash—Dactinomycin—melanoma	0.00013	0.00128	CcSEcCtD
Pemetrexed—Arthralgia—Docetaxel—melanoma	0.00013	0.00128	CcSEcCtD
Pemetrexed—Chest pain—Docetaxel—melanoma	0.00013	0.00128	CcSEcCtD
Pemetrexed—Myalgia—Docetaxel—melanoma	0.00013	0.00128	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000129	0.00127	CcSEcCtD
Pemetrexed—Dizziness—Carmustine—melanoma	0.000128	0.00126	CcSEcCtD
Pemetrexed—Diarrhoea—Temozolomide—melanoma	0.000128	0.00126	CcSEcCtD
Pemetrexed—Anaphylactic shock—Docetaxel—melanoma	0.000124	0.00122	CcSEcCtD
Pemetrexed—Oedema—Docetaxel—melanoma	0.000124	0.00122	CcSEcCtD
Pemetrexed—Dizziness—Temozolomide—melanoma	0.000124	0.00122	CcSEcCtD
Pemetrexed—Infection—Docetaxel—melanoma	0.000123	0.00122	CcSEcCtD
Pemetrexed—Vomiting—Carmustine—melanoma	0.000123	0.00121	CcSEcCtD
Pemetrexed—Nausea—Dactinomycin—melanoma	0.000123	0.00121	CcSEcCtD
Pemetrexed—Shock—Docetaxel—melanoma	0.000122	0.0012	CcSEcCtD
Pemetrexed—Rash—Carmustine—melanoma	0.000122	0.0012	CcSEcCtD
Pemetrexed—Nervous system disorder—Docetaxel—melanoma	0.000122	0.0012	CcSEcCtD
Pemetrexed—Dermatitis—Carmustine—melanoma	0.000122	0.0012	CcSEcCtD
Pemetrexed—Thrombocytopenia—Docetaxel—melanoma	0.000122	0.0012	CcSEcCtD
Pemetrexed—Skin disorder—Docetaxel—melanoma	0.000121	0.00119	CcSEcCtD
Pemetrexed—Vomiting—Temozolomide—melanoma	0.000119	0.00117	CcSEcCtD
Pemetrexed—Anorexia—Docetaxel—melanoma	0.000118	0.00117	CcSEcCtD
Pemetrexed—Rash—Temozolomide—melanoma	0.000118	0.00116	CcSEcCtD
Pemetrexed—Dermatitis—Temozolomide—melanoma	0.000118	0.00116	CcSEcCtD
Pemetrexed—Nausea—Carmustine—melanoma	0.000115	0.00113	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Docetaxel—melanoma	0.000113	0.00111	CcSEcCtD
Pemetrexed—Nausea—Temozolomide—melanoma	0.000111	0.00109	CcSEcCtD
Pemetrexed—Dyspnoea—Docetaxel—melanoma	0.000111	0.00109	CcSEcCtD
Pemetrexed—Dyspepsia—Docetaxel—melanoma	0.000109	0.00108	CcSEcCtD
Pemetrexed—Decreased appetite—Docetaxel—melanoma	0.000108	0.00106	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Docetaxel—melanoma	0.000107	0.00106	CcSEcCtD
Pemetrexed—Fatigue—Docetaxel—melanoma	0.000107	0.00105	CcSEcCtD
Pemetrexed—Constipation—Docetaxel—melanoma	0.000106	0.00105	CcSEcCtD
Pemetrexed—Pain—Docetaxel—melanoma	0.000106	0.00105	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Docetaxel—melanoma	0.000102	0.001	CcSEcCtD
Pemetrexed—Abdominal pain—Docetaxel—melanoma	9.82e-05	0.000967	CcSEcCtD
Pemetrexed—Body temperature increased—Docetaxel—melanoma	9.82e-05	0.000967	CcSEcCtD
Pemetrexed—Hypersensitivity—Docetaxel—melanoma	9.15e-05	0.000901	CcSEcCtD
Pemetrexed—Asthenia—Docetaxel—melanoma	8.91e-05	0.000878	CcSEcCtD
Pemetrexed—Pruritus—Docetaxel—melanoma	8.79e-05	0.000865	CcSEcCtD
Pemetrexed—Diarrhoea—Docetaxel—melanoma	8.5e-05	0.000837	CcSEcCtD
Pemetrexed—Dizziness—Docetaxel—melanoma	8.22e-05	0.000809	CcSEcCtD
Pemetrexed—Vomiting—Docetaxel—melanoma	7.9e-05	0.000778	CcSEcCtD
Pemetrexed—Rash—Docetaxel—melanoma	7.83e-05	0.000771	CcSEcCtD
Pemetrexed—Dermatitis—Docetaxel—melanoma	7.83e-05	0.000771	CcSEcCtD
Pemetrexed—Nausea—Docetaxel—melanoma	7.38e-05	0.000727	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDK2—melanoma	3.56e-05	0.000552	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NPPA—melanoma	3.53e-05	0.000547	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—PRKCA—melanoma	3.52e-05	0.000547	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CUBN—melanoma	3.52e-05	0.000546	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN2B—melanoma	3.5e-05	0.000544	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PDGFRA—melanoma	3.49e-05	0.000542	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—PCNA—melanoma	3.48e-05	0.000539	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PRKCA—melanoma	3.45e-05	0.000536	CbGpPWpGaD
Pemetrexed—DHFR—Disease—VCAN—melanoma	3.44e-05	0.000534	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ERCC2—melanoma	3.43e-05	0.000532	CbGpPWpGaD
Pemetrexed—DHFR—Disease—WNT5A—melanoma	3.42e-05	0.00053	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	3.41e-05	0.000529	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CSPG4—melanoma	3.4e-05	0.000528	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SDHD—melanoma	3.4e-05	0.000528	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—BSG—melanoma	3.4e-05	0.000528	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—PCNA—melanoma	3.39e-05	0.000526	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MAP2K2—melanoma	3.38e-05	0.000524	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDK4—melanoma	3.36e-05	0.000521	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TERT—melanoma	3.36e-05	0.000521	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—ALB—melanoma	3.33e-05	0.000517	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GPAM—melanoma	3.29e-05	0.000511	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.23e-05	0.000501	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—E2F1—melanoma	3.22e-05	0.000499	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PIK3CB—melanoma	3.22e-05	0.000499	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—TERT—melanoma	3.21e-05	0.000498	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HLA-A—melanoma	3.21e-05	0.000498	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PLA2G6—melanoma	3.21e-05	0.000498	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—RAC1—melanoma	3.2e-05	0.000497	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PTGS2—melanoma	3.19e-05	0.000494	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDK2—melanoma	3.18e-05	0.000493	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—PRKCA—melanoma	3.15e-05	0.000489	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ABCB1—melanoma	3.14e-05	0.000488	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.14e-05	0.000487	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDK2—melanoma	3.1e-05	0.000481	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HIF1A—melanoma	3.07e-05	0.000477	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.07e-05	0.000476	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.07e-05	0.000476	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—PCNA—melanoma	3.03e-05	0.000471	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP17A1—melanoma	3.03e-05	0.00047	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—ATM—melanoma	3.02e-05	0.000468	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDK4—melanoma	3e-05	0.000466	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDK4—melanoma	2.93e-05	0.000455	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TERT—melanoma	2.93e-05	0.000455	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—melanoma	2.92e-05	0.000453	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—RB1—melanoma	2.92e-05	0.000453	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CG—melanoma	2.91e-05	0.000451	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	2.9e-05	0.00045	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PRKCA—melanoma	2.89e-05	0.000449	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—VCAN—melanoma	2.88e-05	0.000447	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ERCC2—melanoma	2.87e-05	0.000445	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GNA11—melanoma	2.86e-05	0.000443	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PPARG—melanoma	2.81e-05	0.000436	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PLA2G6—melanoma	2.8e-05	0.000434	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—FASN—melanoma	2.8e-05	0.000434	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOS2—melanoma	2.79e-05	0.000434	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PTEN—melanoma	2.78e-05	0.000431	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDK2—melanoma	2.77e-05	0.00043	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOTCH1—melanoma	2.77e-05	0.000429	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—SLC5A5—melanoma	2.75e-05	0.000427	CbGpPWpGaD
Pemetrexed—DHFR—Disease—GAB2—melanoma	2.74e-05	0.000426	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CD80—melanoma	2.71e-05	0.000421	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—KIT—melanoma	2.71e-05	0.00042	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—APC—melanoma	2.71e-05	0.00042	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FASN—melanoma	2.68e-05	0.000416	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EGF—melanoma	2.67e-05	0.000415	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	2.66e-05	0.000413	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CD44—melanoma	2.66e-05	0.000412	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GNAQ—melanoma	2.66e-05	0.000412	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—ATM—melanoma	2.63e-05	0.000409	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDK4—melanoma	2.62e-05	0.000407	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—RB1—melanoma	2.61e-05	0.000405	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CXCR4—melanoma	2.58e-05	0.0004	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HDAC2—melanoma	2.58e-05	0.0004	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FOXO4—melanoma	2.58e-05	0.0004	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.58e-05	0.0004	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN2A—melanoma	2.57e-05	0.000399	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CD—melanoma	2.56e-05	0.000397	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—RB1—melanoma	2.55e-05	0.000396	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD44—melanoma	2.55e-05	0.000396	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP1B1—melanoma	2.55e-05	0.000395	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—BRAF—melanoma	2.54e-05	0.000395	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ALB—melanoma	2.52e-05	0.000392	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—VCAN—melanoma	2.52e-05	0.00039	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—melanoma	2.47e-05	0.000384	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP17A1—melanoma	2.43e-05	0.000377	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MAP2K1—melanoma	2.39e-05	0.000372	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CD—melanoma	2.38e-05	0.000369	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT3—melanoma	2.35e-05	0.000365	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GNA11—melanoma	2.3e-05	0.000356	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN2A—melanoma	2.3e-05	0.000356	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—RB1—melanoma	2.28e-05	0.000354	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—FGF2—melanoma	2.28e-05	0.000353	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN1B—melanoma	2.27e-05	0.000353	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CG—melanoma	2.27e-05	0.000352	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—IL6—melanoma	2.26e-05	0.000351	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—FASN—melanoma	2.25e-05	0.000349	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—melanoma	2.24e-05	0.000348	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CB—melanoma	2.23e-05	0.000346	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MDM2—melanoma	2.23e-05	0.000346	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLC5A5—melanoma	2.21e-05	0.000343	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTGS2—melanoma	2.21e-05	0.000343	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PPARG—melanoma	2.19e-05	0.000339	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.18e-05	0.000338	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CCND1—melanoma	2.17e-05	0.000337	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GNAQ—melanoma	2.14e-05	0.000331	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CD44—melanoma	2.14e-05	0.000331	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MDM2—melanoma	2.13e-05	0.000331	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP17A1—melanoma	2.12e-05	0.000329	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ERBB2—melanoma	2.1e-05	0.000326	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN1A—melanoma	2.1e-05	0.000326	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ABCB1—melanoma	2.1e-05	0.000325	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERBB4—melanoma	2.08e-05	0.000322	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CB—melanoma	2.07e-05	0.000322	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CD4—melanoma	2.07e-05	0.000321	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDKN2B—melanoma	2.06e-05	0.00032	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTGS2—melanoma	2.05e-05	0.000319	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP1B1—melanoma	2.05e-05	0.000318	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN1B—melanoma	2.03e-05	0.000316	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GNA11—melanoma	2e-05	0.000311	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN2A—melanoma	2e-05	0.000311	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD86—melanoma	1.99e-05	0.000309	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CD—melanoma	1.99e-05	0.000309	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN1B—melanoma	1.98e-05	0.000308	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ALB—melanoma	1.97e-05	0.000305	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—FASN—melanoma	1.96e-05	0.000304	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PIK3CA—melanoma	1.96e-05	0.000304	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CDKN1B—melanoma	1.95e-05	0.000302	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MDM2—melanoma	1.94e-05	0.000302	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CCND1—melanoma	1.94e-05	0.000301	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGF1—melanoma	1.93e-05	0.0003	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PRKCA—melanoma	1.93e-05	0.0003	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC5A5—melanoma	1.93e-05	0.000299	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTEN—melanoma	1.93e-05	0.000299	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ERCC2—melanoma	1.91e-05	0.000297	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CCND1—melanoma	1.89e-05	0.000294	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN1A—melanoma	1.88e-05	0.000291	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PDGFRA—melanoma	1.87e-05	0.00029	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GNAQ—melanoma	1.86e-05	0.000289	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CD44—melanoma	1.86e-05	0.000289	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PRKCA—melanoma	1.85e-05	0.000287	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CTNNB1—melanoma	1.84e-05	0.000285	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERCC2—melanoma	1.84e-05	0.000285	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN1A—melanoma	1.83e-05	0.000284	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MAP2K2—melanoma	1.81e-05	0.000281	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CDKN1A—melanoma	1.8e-05	0.000279	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTEN—melanoma	1.79e-05	0.000278	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MAPK3—melanoma	1.79e-05	0.000278	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP1B1—melanoma	1.79e-05	0.000277	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN1B—melanoma	1.77e-05	0.000275	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MYC—melanoma	1.74e-05	0.00027	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CB—melanoma	1.74e-05	0.000269	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TERT—melanoma	1.72e-05	0.000267	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HLA-A—melanoma	1.72e-05	0.000267	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTGS2—melanoma	1.72e-05	0.000267	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RAC1—melanoma	1.72e-05	0.000266	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MAPK1—melanoma	1.7e-05	0.000264	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CCND1—melanoma	1.69e-05	0.000263	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ABCB1—melanoma	1.69e-05	0.000262	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HIF1A—melanoma	1.65e-05	0.000256	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN1A—melanoma	1.64e-05	0.000254	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—STAT3—melanoma	1.6e-05	0.000249	CbGpPWpGaD
Pemetrexed—GART—Metabolism—AKT1—melanoma	1.6e-05	0.000248	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MAPK3—melanoma	1.6e-05	0.000248	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NRAS—melanoma	1.6e-05	0.000248	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MAPK3—melanoma	1.56e-05	0.000242	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MYC—melanoma	1.56e-05	0.000241	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PRKCA—melanoma	1.55e-05	0.000241	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ERCC2—melanoma	1.54e-05	0.000239	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MAPK3—melanoma	1.53e-05	0.000238	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MAPK1—melanoma	1.52e-05	0.000236	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MYC—melanoma	1.52e-05	0.000236	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CG—melanoma	1.51e-05	0.000235	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTEN—melanoma	1.5e-05	0.000233	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS2—melanoma	1.5e-05	0.000232	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MYC—melanoma	1.49e-05	0.000231	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MAPK1—melanoma	1.49e-05	0.000231	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOTCH1—melanoma	1.48e-05	0.00023	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ABCB1—melanoma	1.47e-05	0.000228	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PPARG—melanoma	1.46e-05	0.000226	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MAPK1—melanoma	1.46e-05	0.000226	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EGFR—melanoma	1.46e-05	0.000226	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD80—melanoma	1.45e-05	0.000226	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APC—melanoma	1.45e-05	0.000225	CbGpPWpGaD
Pemetrexed—DHFR—Disease—KIT—melanoma	1.45e-05	0.000225	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EGF—melanoma	1.43e-05	0.000223	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MAPK3—melanoma	1.4e-05	0.000217	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—KRAS—melanoma	1.38e-05	0.000213	CbGpPWpGaD
Pemetrexed—DHFR—Disease—BRAF—melanoma	1.36e-05	0.000212	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CA—melanoma	1.36e-05	0.000211	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MYC—melanoma	1.36e-05	0.000211	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PRKCA—melanoma	1.35e-05	0.00021	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ERCC2—melanoma	1.34e-05	0.000208	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CD—melanoma	1.33e-05	0.000206	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MAPK1—melanoma	1.33e-05	0.000206	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALB—melanoma	1.31e-05	0.000204	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MAP2K1—melanoma	1.28e-05	0.000199	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—melanoma	1.28e-05	0.000198	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CD—melanoma	1.28e-05	0.000198	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CA—melanoma	1.26e-05	0.000196	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGF2—melanoma	1.22e-05	0.00019	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CG—melanoma	1.22e-05	0.000189	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPARG—melanoma	1.17e-05	0.000182	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HRAS—melanoma	1.17e-05	0.000181	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CB—melanoma	1.16e-05	0.00018	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTGS2—melanoma	1.15e-05	0.000178	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MDM2—melanoma	1.14e-05	0.000177	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERBB2—melanoma	1.13e-05	0.000175	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6—melanoma	1.12e-05	0.000174	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—melanoma	1.12e-05	0.000173	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CB—melanoma	1.11e-05	0.000173	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—AKT1—melanoma	1.11e-05	0.000172	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD4—melanoma	1.11e-05	0.000172	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTGS2—melanoma	1.1e-05	0.000171	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CD—melanoma	1.07e-05	0.000166	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CG—melanoma	1.06e-05	0.000165	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CA—melanoma	1.06e-05	0.000164	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALB—melanoma	1.05e-05	0.000164	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDKN1B—melanoma	1.04e-05	0.000162	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT1—melanoma	1.03e-05	0.00016	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPARG—melanoma	1.02e-05	0.000159	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTEN—melanoma	1e-05	0.000155	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CTNNB1—melanoma	9.86e-06	0.000153	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDKN1A—melanoma	9.63e-06	0.000149	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTEN—melanoma	9.61e-06	0.000149	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CD—melanoma	9.32e-06	0.000145	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CB—melanoma	9.31e-06	0.000144	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTGS2—melanoma	9.23e-06	0.000143	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALB—melanoma	9.2e-06	0.000143	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AKT1—melanoma	8.65e-06	0.000134	CbGpPWpGaD
Pemetrexed—DHFR—Disease—STAT3—melanoma	8.59e-06	0.000133	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NRAS—melanoma	8.57e-06	0.000133	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MAPK3—melanoma	8.21e-06	0.000127	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CB—melanoma	8.12e-06	0.000126	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTGS2—melanoma	8.05e-06	0.000125	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTEN—melanoma	8.05e-06	0.000125	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MYC—melanoma	7.98e-06	0.000124	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MAPK1—melanoma	7.81e-06	0.000121	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EGFR—melanoma	7.81e-06	0.000121	CbGpPWpGaD
Pemetrexed—DHFR—Disease—KRAS—melanoma	7.38e-06	0.000114	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CA—melanoma	7.06e-06	0.00011	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTEN—melanoma	7.02e-06	0.000109	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CA—melanoma	6.78e-06	0.000105	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HRAS—melanoma	6.27e-06	9.73e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6—melanoma	6e-06	9.31e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AKT1—melanoma	5.77e-06	8.95e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CA—melanoma	5.68e-06	8.81e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT1—melanoma	5.54e-06	8.59e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CA—melanoma	4.95e-06	7.69e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AKT1—melanoma	4.64e-06	7.19e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKT1—melanoma	4.05e-06	6.28e-05	CbGpPWpGaD
